🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsBuyer Beware⚠ Counterfeit Ozempic pens circulating — looking for input Page 4

⚠ Counterfeit Ozempic pens circulating — looking for input

ingrid_STO Wed, Mar 5, 2025 at 4:50 PM 17 replies 1,756 viewsPage 4 of 4
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Mar 9, 2025 at 9:50 AM#16

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

3 1rachel_ABQ, traveltech_sara, AttorneyGrant
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Mar 9, 2025 at 12:24 PM#17

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

4 2tommy_boulder, hyun_seoul, jim_asheville and 1 other
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 9, 2025 at 2:58 PM#18
Dr.PeteFamMed said:
The useful move here is to separate what is established from what is widely repeated.

This matches mine closely enough to be worth saying so. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

5 3maya_sedona, stefan_berlin, Dr.EM_Chicago and 2 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Mar 9, 2025 at 5:32 PM#19
Dr.PeteFamMed said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

6 4SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 3 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 9, 2025 at 8:06 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

28 1PurityPaulOR, MaxMetOK, MounjBrad and 25 others
Reply Quote Save Share Report

Similar Threads

⚠ Peptide Sciences SHUT DOWN March 6, 2026 — what happened and what to do now8 replies
⚠ Amino Asylum raided by FDA June 2025 — warehouse seized6 replies
⚠ Swiss Chems FDA warning letter December 2024 — selling unapproved drugs6 replies
⚠ 50+ FDA warning letters sent to peptide vendors in 2025 — full list4 replies
⚠ PeptideMeter exposed: some vendors scoring E grade on basic peptides4 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register